ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

DCIS

  • Home
  • DCIS
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Active Clinical Trials
  • From the Co-Chairs
  • Institution Spotlights
  • News in Brief
  • People
  • Special Topics
  • Trial Results
  • All
  • AACR
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia
  • Adolescents and young adults
  • Advanced melanoma
  • Advanced practice providers
  • Advocacy
  • Anal cancer
  • ARPA-H
  • ASCO
  • Awards
  • AYA cancer
  • B-cell lymphoma
  • Big data
  • Biostatistics
  • Bladder cancer
  • Blood cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer
  • Cancer care delivery research
  • Cancer control
  • Cancer research
  • Cancer research policy
  • Cancer screening
  • Cancer surveillance
  • Cardiotoxicity
  • CBPF
  • Chemoimmunotherapy
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia
  • Clinical trial
  • Clinical trials
  • Colorectal cancer
  • Colorectal liver metastases
  • ComboMATCH
  • Comis Symposium
  • Communication
  • Community oncology
  • Cooperative Group cancer research
  • Correlative science
  • COVID-19
  • CT scans
  • Data science
  • DCIS
  • De-escalation
  • Deep learning
  • DEI
  • Developmental therapeutics
  • Diversity
  • EGFR
  • Engineering
  • Esophagus cancer
  • Ethics
  • Federally-funded cancer research
  • Financial hardship
  • Gallbladder cancer
  • Gastric cancer
  • Gastroesophageal junction cancer
  • GBM
  • Gender equity
  • Genetic testing
  • Genomics
  • Geriatric oncology
  • GI cancer
  • Glioblastoma
  • GM-CSF
  • Green tea catechins
  • Group Meeting
  • GU cancer
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • health care
  • Health care administration
  • Health equity
  • Hematology
  • Hepatic arterial infusion
  • HER2-positive breast cancer
  • Hormone therapy
  • Imaging
  • Immune checkpoint inhibitors
  • Immunotherapy
  • In memory
  • Institution Evaluation
  • Just-in-time clinical trials
  • Kidney cancer
  • Language
  • Leadership
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lung inflammation
  • Lymphoblastic lymphoma
  • Lymphoma
  • Mammography
  • Meetings
  • Melanoma
  • Mentorship
  • Mesothelioma
  • Misinformation
  • Multiple myeloma
  • Myelodysplastic neoplasms
  • Myelodysplastic syndromes
  • Myeloid malignancies
  • Myeloma
  • myeloMATCH
  • National Cancer Act
  • Natural language processing
  • NCI
  • NCI-Designated Comprehensive Cancer Centers
  • NCI-MATCH
  • NCORP
  • NCTN Grant
  • Neuroendocrine tumors
  • NIH
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • NSCLC
  • Older adults
  • Ovarian cancer
  • Pancreatic cancer
  • Pancreatic cyst
  • Pancreatic cysts
  • Pancreatic NETs
  • Pathology
  • Patient care
  • Patient registry
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral neuropathy
  • Personalized medicine
  • Personalized screening
  • Pneumonitis
  • Policy
  • Pragmatic clinical trials
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Proteasome inhibitors
  • Public-private partnerships
  • Quality of life
  • Racism
  • Radiation
  • Radiology
  • Rare disease
  • Real-world data
  • Recurrence
  • Renal cell
  • Renal cell carcinoma
  • Reproductive health
  • Research results
  • Retroperitoneal sarcoma
  • Sarcoma
  • Scholarship
  • Sexuality
  • Side effects
  • Smoking cessation
  • Smoldering multiple myeloma
  • Social determinants of health
  • Social genomics
  • Stomach cancer
  • Survivorship
  • Symptom control
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • TMIST
  • Tobacco cessation
  • Translational research
  • Urinary tract cancer
  • Vaccination
  • Women in oncology
  • Young investigators
  • All
  • Diane Dragaud
  • ECOG-ACRIN Staff
  • ECOG-ACRIN Staff
August 28, 2025
News in Brief
August 28, 2025
Categories
  • News in Brief

News in Brief, August 2025

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more
July 10, 2025
News in Brief
July 10, 2025
Categories
  • News in Brief

News in Brief, July 2025

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Comis Symposium Communication COVID-19 GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Pancreatic cyst Patient-reported outcomes Precision medicine Prevention Prostate cancer Real-world data Research results Sarcoma Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc